KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Acquisitions (2016 - 2019)

Historic Acquisitions for Edwards Lifesciences (EW) over the last 7 years, with Q2 2019 value amounting to $65.2 million.

  • Edwards Lifesciences' Acquisitions rose 372222.22% to $65.2 million in Q2 2019 from the same period last year, while for Sep 2020 it was $65.2 million, marking a year-over-year decrease of 3493.01%. This contributed to the annual value of $100.2 million for FY2019, which is N/A changed from last year.
  • Edwards Lifesciences' Acquisitions amounted to $65.2 million in Q2 2019, which was up 372222.22% from $35.0 million recorded in Q1 2019.
  • Edwards Lifesciences' Acquisitions' 5-year high stood at $320.8 million during Q3 2015, with a 5-year trough of -$1.8 million in Q2 2018.
  • Moreover, its 5-year median value for Acquisitions was $3.1 million (2016), whereas its average is $48.7 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Acquisitions skyrocketed by 422000.0% in 2017, and later tumbled by 16428.57% in 2018.
  • Over the past 5 years, Edwards Lifesciences' Acquisitions (Quarter) stood at $11.5 million in 2015, then plummeted by 78.26% to $2.5 million in 2016, then surged by 4220.0% to $108.0 million in 2017, then tumbled by 101.67% to -$1.8 million in 2018, then soared by 3722.22% to $65.2 million in 2019.
  • Its last three reported values are $65.2 million in Q2 2019, $35.0 million for Q1 2019, and -$1.8 million during Q2 2018.